OraSure Technologies Sets 2007 Annual Meeting Date
27 Ottobre 2006 - 3:55PM
Business Wire
OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that its
2007 Annual Meeting of Stockholders is scheduled to be held on
Tuesday, May 15, 2007, at the Historic Hotel Bethlehem, Bethlehem,
Pennsylvania. Stockholder proposals must be received no later than
December 9, 2006, in order to be considered for inclusion in the
Company�s Proxy Statement under relevant Securities and Exchange
Commission rules and no later than February 14, 2007, in order to
be considered at the Annual Meeting or to nominate a Director under
OraSure Technologies� Bylaws. About OraSure Technologies OraSure
Technologies develops, manufactures and markets oral fluid specimen
collection devices using proprietary oral fluid technologies,
diagnostic products including immunoassays and other in vitro
diagnostic tests, and other medical devices. These products are
sold in the United States as well as internationally to various
clinical laboratories, hospitals, clinics, community-based
organizations and other public health organizations, distributors,
government agencies, physicians� offices, and commercial and
industrial entities. OraSure Technologies is the leading supplier
of oral-fluid collection devices and assays to the life insurance
industry and public health markets for the detection of antibodies
to HIV. In addition, the Company supplies oral-fluid testing
solutions for drugs of abuse testing. For more information on the
Company, please go to www.orasure.com. OraSure Technologies, Inc.
(NASDAQ:OSUR) today announced that its 2007 Annual Meeting of
Stockholders is scheduled to be held on Tuesday, May 15, 2007, at
the Historic Hotel Bethlehem, Bethlehem, Pennsylvania. Stockholder
proposals must be received no later than December 9, 2006, in order
to be considered for inclusion in the Company's Proxy Statement
under relevant Securities and Exchange Commission rules and no
later than February 14, 2007, in order to be considered at the
Annual Meeting or to nominate a Director under OraSure
Technologies' Bylaws. About OraSure Technologies OraSure
Technologies develops, manufactures and markets oral fluid specimen
collection devices using proprietary oral fluid technologies,
diagnostic products including immunoassays and other in vitro
diagnostic tests, and other medical devices. These products are
sold in the United States as well as internationally to various
clinical laboratories, hospitals, clinics, community-based
organizations and other public health organizations, distributors,
government agencies, physicians' offices, and commercial and
industrial entities. OraSure Technologies is the leading supplier
of oral-fluid collection devices and assays to the life insurance
industry and public health markets for the detection of antibodies
to HIV. In addition, the Company supplies oral-fluid testing
solutions for drugs of abuse testing. For more information on the
Company, please go to www.orasure.com.
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Set 2024 a Ott 2024
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Ott 2023 a Ott 2024